Over 14,000 patients received injections from this batch of contaminated drugs
Oral semaglutide (Rybelsus) is already approved and marketed
Top key opinion leaders (KOLs), dermatologists, and surgeons who treat these patients every day are raising the same red flags: What theyre seeing clinically: Hollowing of the anterior face, under-eye area, and jowls Increased laxity in the face, neck, arms, and abdomen Loose, redundant skin after facial volume drops Dull, dehydrated, lifeless skin tone A decline in skin elasticity and radiance Skin behaving older than the patients age Dr
Headaches Headaches are reported by approximately 10% to 15% of GLP-1 users, typically in the first few weeks
Semaglutide 2.4 mg for the treatment of obesity: Key elements of the STEP trials 1 to 5
More Supplies Disclosure: supply links may earn PepPal a commission at no cost to you